Literature DB >> 30621516

Mucosal miR-3677 is over-expressed in cirrhotic patients with gastric antral vascular ectasia (GAVE).

Michał Żorniak1, Wojciech Garczorz2, Piotr Wosiewicz1, Tomasz Marek1, Małgorzata Błaszczyńska3, Marek Waluga1, Michał Kukla1, Małgorzata Kimsa-Furdzik2, Tomasz Francuz2, Marek Hartleb1.   

Abstract

INTRODUCTION: Gastric antral vascular ectasia (GAVE) is a rare vasculopathy that associates several diseases, most commonly liver cirrhosis. It usually presents as an occult gastrointestinal bleeding leading to profound iron deficiency anemia. We hypothesized that GAVE is local mucosal pathology dependent on genetic mechanisms, and the purpose of the study was to characterize miRNAs expression in gastric tissue of patients with cirrhosis and GAVE.
MATERIALS AND METHODS: Thirteen patients with GAVE and cirrhosis and 35 healthy subjects were recruited. Microarray analysis and comparative microRNA study was done by quantitative polymerase chain reaction (qPCR). The microarray scores were grouped with use of the hierarchical clusterization analysis and miRNA target prediction was done with TargetScan 6.2 algorithm and Gene Ontology analysis (DIANA-miRPath).
RESULTS: Concentration of miR-3677 in GAVE-affected mucosa was higher by 72% in comparison with GAVE-free mucosa of patients with cirrhosis (33.7 vs. 35.6 PCR cycles; p < .001) and by 45% in comparison with normal mucosa (33.7 vs. 34.9 PCR cycles; p < .05). According to Gene Ontology analysis miR-3677 was related to angiopoietin-like protein 4 (ANGPTL4) gene.
CONCLUSION: GAVE in liver cirrhosis is associated with increased expression of miR-3667 that may be linked with ANGPTL4 gene.

Entities:  

Keywords:  ANGPTL4 gene; GAVE; gastric antral vascular ectasia; liver cirrhosis; miR-3667; microRNA

Mesh:

Substances:

Year:  2019        PMID: 30621516     DOI: 10.1080/00365521.2018.1547922

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis.

Authors:  Hai-Xiang Mao; Bai-Wen Chen; Jie Wang; Chen-Yang Ma; Yi-Chao Gan; Kai-Jie Qiu
Journal:  Exp Ther Med       Date:  2021-05-19       Impact factor: 2.447

2.  Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma.

Authors:  Shijie Qin; Jieyun Xu; Yunmeng Yi; Sizhu Jiang; Ping Jin; Xinyi Xia; Fei Ma
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

3.  The therapeutic value of the SphK1-targeting microRNA-3677 in human osteosarcoma cells.

Authors:  Chen Yao; Jian-Wei Ruan; Yun-Rong Zhu; Fei Liu; Hui-Ming Wu; Yan Zhang; Qing Jiang
Journal:  Aging (Albany NY)       Date:  2020-03-23       Impact factor: 5.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.